ATE420115T1 - Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs - Google Patents

Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs

Info

Publication number
ATE420115T1
ATE420115T1 AT03760023T AT03760023T ATE420115T1 AT E420115 T1 ATE420115 T1 AT E420115T1 AT 03760023 T AT03760023 T AT 03760023T AT 03760023 T AT03760023 T AT 03760023T AT E420115 T1 ATE420115 T1 AT E420115T1
Authority
AT
Austria
Prior art keywords
mab
monoclonal antibody
aurora
optionally
diagnosing
Prior art date
Application number
AT03760023T
Other languages
German (de)
English (en)
Inventor
Claude Prigent
Anne Martin
Original Assignee
Centre Nat Rech Scient
Sang Bretagne Ets Franc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Sang Bretagne Ets Franc filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE420115T1 publication Critical patent/ATE420115T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03760023T 2002-06-12 2003-06-12 Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs ATE420115T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207212A FR2840905B1 (fr) 2002-06-12 2002-06-12 Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers

Publications (1)

Publication Number Publication Date
ATE420115T1 true ATE420115T1 (de) 2009-01-15

Family

ID=29595167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03760023T ATE420115T1 (de) 2002-06-12 2003-06-12 Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs

Country Status (9)

Country Link
US (1) US7514231B2 (https=)
EP (1) EP1511771B1 (https=)
JP (1) JP4555681B2 (https=)
AT (1) ATE420115T1 (https=)
AU (1) AU2003255671A1 (https=)
CA (1) CA2489214C (https=)
DE (1) DE60325725D1 (https=)
FR (1) FR2840905B1 (https=)
WO (1) WO2003106500A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
EP1778669A2 (en) 2004-08-18 2007-05-02 Takeda San Diego, Inc. Kinase inhibitors
ATE479687T1 (de) 2004-10-15 2010-09-15 Takeda Pharmaceutical Kinaseinhibitoren
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655369A1 (en) * 1995-12-18 2006-05-10 Sugen, Inc. Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders

Also Published As

Publication number Publication date
DE60325725D1 (de) 2009-02-26
FR2840905B1 (fr) 2006-07-07
US20070117163A1 (en) 2007-05-24
AU2003255671A8 (en) 2003-12-31
FR2840905A1 (fr) 2003-12-19
WO2003106500A1 (fr) 2003-12-24
CA2489214A1 (fr) 2003-12-24
AU2003255671A1 (en) 2003-12-31
JP2006513135A (ja) 2006-04-20
EP1511771A1 (fr) 2005-03-09
JP4555681B2 (ja) 2010-10-06
CA2489214C (fr) 2013-08-06
US7514231B2 (en) 2009-04-07
EP1511771B1 (fr) 2009-01-07

Similar Documents

Publication Publication Date Title
Grünewald et al. Ewing sarcoma
Knittel et al. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-) fibroblast subpopulations in hepatic tissue repair
DE69929185T2 (de) Tumormarker
ATE538809T1 (de) Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
RU2007139912A (ru) Способ прогнозирования течения рака на основе количественного анализа клеточного рецептора витамина фолата
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
RU2007141067A (ru) Терапия с помощью антител к egfr, основанная на повышенном числе копий гена egfr в опухолевых тканях
Ratkaj et al. Microarray analysis of Dupuytren’s disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway
DE60239059D1 (de) Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums beingen einer antiöstrogen-therapie resistent sind
EP3008210A1 (en) Methods for detecting prostate cancer
Mak et al. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells
DE602005017519D1 (de) Automatische glykofingerabdruck-strategie
WO2016203053A3 (en) Methods of characterising cancer
Larsen et al. Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma
CN1928563A (zh) 乳腺癌的免疫组化诊断试剂盒和测试片
ATE420115T1 (de) Monoklonaler antikörper gegen aurora-a, seine herstellungsverfahren und seine verwendung zur diagnose und zur behandlung von krebs
RU2007141930A (ru) Способ in vitro идентификации соединений для лечения рака
IL190401A0 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
FR2919061B1 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
Zhang et al. Label-free biosensor for non-invasive and low-cost detection of metastatic risk through urine biopsy
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
ATE366936T1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2004040312A3 (fr) Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
ATE406579T1 (de) Verfahren zur diagnose von tumoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties